| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Jarid Goodman, Mark G Packar. The influence of cannabinoids on learning and memory processes of the dorsal striatum. Neurobiology of learning and memory. vol 125. 2016-09-09. PMID:26092091. |
in addition, the enhancing effect of repeated cannabinoid exposure on habit memory suggests a novel neurobehavioral mechanism for marijuana addiction involving the dorsal striatum-dependent memory system. |
2016-09-09 |
2023-08-13 |
mouse |
| Dayong Lee, Mateus M Bergamaschi, Garry Milman, Allan J Barnes, Regina H C Queiroz, Ryan Vandrey, Marilyn A Huesti. Plasma Cannabinoid Pharmacokinetics After Controlled Smoking and Ad libitum Cannabis Smoking in Chronic Frequent Users. Journal of analytical toxicology. vol 39. issue 8. 2016-09-09. PMID:26378131. |
plasma cannabinoid pharmacokinetics after controlled smoking and ad libitum cannabis smoking in chronic frequent users. |
2016-09-09 |
2023-08-13 |
human |
| Dayong Lee, Mateus M Bergamaschi, Garry Milman, Allan J Barnes, Regina H C Queiroz, Ryan Vandrey, Marilyn A Huesti. Plasma Cannabinoid Pharmacokinetics After Controlled Smoking and Ad libitum Cannabis Smoking in Chronic Frequent Users. Journal of analytical toxicology. vol 39. issue 8. 2016-09-09. PMID:26378131. |
these data greatly expand prior research findings on cannabinoid excretion profiles in chronic frequent cannabis smokers during ad libitum smoking. |
2016-09-09 |
2023-08-13 |
human |
| Dayong Lee, Mateus M Bergamaschi, Garry Milman, Allan J Barnes, Regina H C Queiroz, Ryan Vandrey, Marilyn A Huesti. Plasma Cannabinoid Pharmacokinetics After Controlled Smoking and Ad libitum Cannabis Smoking in Chronic Frequent Users. Journal of analytical toxicology. vol 39. issue 8. 2016-09-09. PMID:26378131. |
the chronic frequent cannabis smokers exhibited extended detection windows for plasma cannabinoids, reflecting a large cannabinoid body burden. |
2016-09-09 |
2023-08-13 |
human |
| Nikolas P Lemos, Alexander C San Nicolas, Justin A Volk, Eric A Ingle, Chinyere M William. Driving Under the Influence of Marijuana Versus Driving and Dying Under the Influence of Marijuana: A Comparison of Blood Concentrations of Δ9-Tetrahydrocannabinol, 11-Hydroxy-Δ9-Tetrahydrocannabinol, 11-Nor-9-Carboxy-Δ9-Tetrahydrocannabinol and Other Cannabinoids in Arrested Drivers Versus Deceased Drivers. Journal of analytical toxicology. vol 39. issue 8. 2016-09-09. PMID:26378132. |
driving under the influence of marijuana versus driving and dying under the influence of marijuana: a comparison of blood concentrations of Δ9-tetrahydrocannabinol, 11-hydroxy-Δ9-tetrahydrocannabinol, 11-nor-9-carboxy-Δ9-tetrahydrocannabinol and other cannabinoids in arrested drivers versus deceased drivers. |
2016-09-09 |
2023-08-13 |
Not clear |
| Nikolas P Lemos, Alexander C San Nicolas, Justin A Volk, Eric A Ingle, Chinyere M William. Driving Under the Influence of Marijuana Versus Driving and Dying Under the Influence of Marijuana: A Comparison of Blood Concentrations of Δ9-Tetrahydrocannabinol, 11-Hydroxy-Δ9-Tetrahydrocannabinol, 11-Nor-9-Carboxy-Δ9-Tetrahydrocannabinol and Other Cannabinoids in Arrested Drivers Versus Deceased Drivers. Journal of analytical toxicology. vol 39. issue 8. 2016-09-09. PMID:26378132. |
cannabis intoxication in living and deceased drivers is an important medico-legal topic, but only a limited number of studies examine cannabinoids in living and deceased humans. |
2016-09-09 |
2023-08-13 |
Not clear |
| Allan J Barnes, Eliani Spinelli, Sheena Young, Thomas M Martin, Kevin L Kleete, Marilyn A Huesti. Validation of an ELISA Synthetic Cannabinoids Urine Assay. Therapeutic drug monitoring. vol 37. issue 5. 2016-09-08. PMID:25706046. |
synthetic cannabinoids are touted as legal alternatives to cannabis, at least when first released, and routine urine cannabinoid screening methods do not detect these novel psychoactive substances. |
2016-09-08 |
2023-08-13 |
Not clear |
| George D Weiblen, Jonathan P Wenger, Kathleen J Craft, Mahmoud A ElSohly, Zlatko Mehmedic, Erin L Treiber, M David Mark. Gene duplication and divergence affecting drug content in Cannabis sativa. The New phytologist. vol 208. issue 4. 2016-09-06. PMID:26189495. |
marijuana and hemp were crossed to evaluate competing models of cannabinoid inheritance and to explain the predominance of tetrahydrocannabinolic acid (thca) in marijuana compared with cannabidiolic acid (cbda) in hemp. |
2016-09-06 |
2023-08-13 |
Not clear |
| María Salazar, Mar Lorente, Alba Orea-Soufi, David Dávila, Tatiana Erazo, José Lizcano, Arkaitz Carracedo, Endre Kiss-Toth, Guillermo Velasc. Oncosuppressive functions of tribbles pseudokinase 3. Biochemical Society transactions. vol 43. issue 5. 2016-08-31. PMID:26517935. |
in this article, we summarize several observation obtained by our laboratories supporting that trib3 plays a crucial role in the anti-cancer activity of cannabinoids (a novel family of potential anti-cancer agents derived from marijuana) and that trib3 genetic inactivation enhances cancer generation and progression. |
2016-08-31 |
2023-08-13 |
Not clear |
| Stefan S du Plessis, Ashok Agarwal, Arun Syria. Marijuana, phytocannabinoids, the endocannabinoid system, and male fertility. Journal of assisted reproduction and genetics. vol 32. issue 11. 2016-08-25. PMID:26277482. |
marijuana, phytocannabinoids, the endocannabinoid system, and male fertility. |
2016-08-25 |
2023-08-13 |
Not clear |
| Stefan S du Plessis, Ashok Agarwal, Arun Syria. Marijuana, phytocannabinoids, the endocannabinoid system, and male fertility. Journal of assisted reproduction and genetics. vol 32. issue 11. 2016-08-25. PMID:26277482. |
male factor infertility is on the increase, and the exposure to the cannabinoid compounds released by marijuana could be a contributing cause. |
2016-08-25 |
2023-08-13 |
Not clear |
| Adriaan W Bruijnzeel, Xiaoli Qi, Lidia V Guzhva, Shannon Wall, Jie V Deng, Mark S Gold, Marcelo Febo, Barry Setlo. Behavioral Characterization of the Effects of Cannabis Smoke and Anandamide in Rats. PloS one. vol 11. issue 4. 2016-08-25. PMID:27065006. |
however, cannabis contains many other cannabinoids that affect brain function. |
2016-08-25 |
2023-08-13 |
rat |
| Adriaan W Bruijnzeel, Xiaoli Qi, Lidia V Guzhva, Shannon Wall, Jie V Deng, Mark S Gold, Marcelo Febo, Barry Setlo. Behavioral Characterization of the Effects of Cannabis Smoke and Anandamide in Rats. PloS one. vol 11. issue 4. 2016-08-25. PMID:27065006. |
it was also investigated if cannabis smoke exposure leads to tolerance to the locomotor-suppressant effects of the endogenous cannabinoid anandamide. |
2016-08-25 |
2023-08-13 |
rat |
| Jeffrey C Raber, Sytze Elzinga, Charles Kapla. Understanding dabs: contamination concerns of cannabis concentrates and cannabinoid transfer during the act of dabbing. The Journal of toxicological sciences. vol 40. issue 6. 2016-08-22. PMID:26558460. |
understanding dabs: contamination concerns of cannabis concentrates and cannabinoid transfer during the act of dabbing. |
2016-08-22 |
2023-08-13 |
Not clear |
| Jeffrey C Raber, Sytze Elzinga, Charles Kapla. Understanding dabs: contamination concerns of cannabis concentrates and cannabinoid transfer during the act of dabbing. The Journal of toxicological sciences. vol 40. issue 6. 2016-08-22. PMID:26558460. |
this paper investigates cannabinoid transfer efficiency, chemical composition and contamination of concentrated cannabis extracts used for dabbing. |
2016-08-22 |
2023-08-13 |
Not clear |
| R B Laprairie, A M Bagher, M E M Kelly, E M Denovan-Wrigh. Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor. British journal of pharmacology. vol 172. issue 20. 2016-08-18. PMID:26218440. |
cannabidiol is a negative allosteric modulator of the cannabinoid cb1 receptor. |
2016-08-18 |
2023-08-13 |
Not clear |
| R B Laprairie, A M Bagher, M E M Kelly, E M Denovan-Wrigh. Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor. British journal of pharmacology. vol 172. issue 20. 2016-08-18. PMID:26218440. |
cannabidiol has been reported to act as an antagonist at cannabinoid cb1 receptors. |
2016-08-18 |
2023-08-13 |
Not clear |
| R B Laprairie, A M Bagher, M E M Kelly, E M Denovan-Wrigh. Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor. British journal of pharmacology. vol 172. issue 20. 2016-08-18. PMID:26218440. |
we hypothesized that cannabidiol would inhibit cannabinoid agonist activity through negative allosteric modulation of cb1 receptors. |
2016-08-18 |
2023-08-13 |
Not clear |
| E Alfonso Romero-Sandoval, Scott Asbill, Candler A Paige, Kiara Byrd-Glove. Peripherally Restricted Cannabinoids for the Treatment of Pain. Pharmacotherapy. vol 35. issue 10. 2016-08-15. PMID:26497478. |
the use of cannabinoids for the treatment of chronic diseases has increased in the united states, with 23 states having legalized the use of marijuana. |
2016-08-15 |
2023-08-13 |
Not clear |
| E Alfonso Romero-Sandoval, Scott Asbill, Candler A Paige, Kiara Byrd-Glove. Peripherally Restricted Cannabinoids for the Treatment of Pain. Pharmacotherapy. vol 35. issue 10. 2016-08-15. PMID:26497478. |
although currently available cannabinoid compounds have shown effectiveness in relieving symptoms associated with numerous diseases, the use of cannabis or cannabinoids is still controversial mostly due to their psychotropic effects (e.g., euphoria, laughter) or central nervous system (cns)-related undesired effects (e.g., tolerance, dependence). |
2016-08-15 |
2023-08-13 |
Not clear |